Risk Factors for Graft Rejection in Penetrating Keratoplasty Labbafinejad Medical Center Department of Ophthalmology 2002.

Slides:



Advertisements
Similar presentations
Donors Per Million Population
Advertisements

Números.
AGVISE Laboratories %Zone or Grid Samples – Northwood laboratory
Trend for Precision Soil Testing % Zone or Grid Samples Tested compared to Total Samples.
Chapter 4 Sampling Distributions and Data Descriptions.
1
EuroCondens SGB E.
Worksheets.
STATISTICS HYPOTHESES TEST (I)
Addition and Subtraction Equations
OPTN Modifications to Heart Allocation Policy Implemented July 12, 2006 Changed the allocation order for medically urgent (Status 1A and 1B) patients Policy.
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2006 J Heart Lung Transplant 2006;25:
HEART-LUNG TRANSPLANTATION Overall ISHLT 2005 J Heart Lung Transplant 2005;24:
HEART-LUNG TRANSPLANTATION Overall ISHLT 2008 J Heart Lung Transplant 2008;27:
HEART-LUNG TRANSPLANTATION Overall 2010 ISHLT J Heart Lung Transplant Oct; 29 (10):
HEART TRANSPLANTATION Pediatric Recipients ISHLT 2007 J Heart Lung Transplant 2007;26:
HEART TRANSPLANTATION Pediatric Recipients ISHLT 2008 J Heart Lung Transplant 2008;27:
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2007 J Heart Lung Transplant 2007;26.
David Burdett May 11, 2004 Package Binding for WS CDL.
CALENDAR.
The 5S numbers game..
突破信息检索壁垒 -SciFinder Scholar 介绍
A Fractional Order (Proportional and Derivative) Motion Controller Design for A Class of Second-order Systems Center for Self-Organizing Intelligent.
Media-Monitoring Final Report April - May 2010 News.
The basics for simulations
March 2004; Revised July 2006, November 2010
PP Test Review Sections 6-1 to 6-6
Frequency Tables and Stem-and-Leaf Plots 1-3
Exarte Bezoek aan de Mediacampus Bachelor in de grafische en digitale media April 2014.
Copyright © 2012, Elsevier Inc. All rights Reserved. 1 Chapter 7 Modeling Structure with Blocks.
Progressive Aerobic Cardiovascular Endurance Run
Adding Up In Chunks.
MaK_Full ahead loaded 1 Alarm Page Directory (F11)
PROCESS vs. WA State SCS Study A Comparison of Study Design, Patient Population, and Outcomes August 29,2007.
2011 WINNISQUAM COMMUNITY SURVEY YOUTH RISK BEHAVIOR GRADES 9-12 STUDENTS=1021.
Before Between After.
2011 FRANKLIN COMMUNITY SURVEY YOUTH RISK BEHAVIOR GRADES 9-12 STUDENTS=332.
Foundation Stage Results CLL (6 or above) 79% 73.5%79.4%86.5% M (6 or above) 91%99%97%99% PSE (6 or above) 96%84%100%91.2%97.3% CLL.
Subtraction: Adding UP
The Effect of Peloid Application in Out-patient Setting on Knee Osteoarthritis Results of a Pilot Study E Odabaşı, R Tekin, H Erdem, İ.Şimşek, M Turan.
Static Equilibrium; Elasticity and Fracture
Resistência dos Materiais, 5ª ed.
Lial/Hungerford/Holcomb/Mullins: Mathematics with Applications 11e Finite Mathematics with Applications 11e Copyright ©2015 Pearson Education, Inc. All.
Schutzvermerk nach DIN 34 beachten 05/04/15 Seite 1 Training EPAM and CANopen Basic Solution: Password * * Level 1 Level 2 * Level 3 Password2 IP-Adr.
Irrigation Vs. Non- Irrigating Corneal flap interface In the Management of Grade II – III Diffuse Lamellar Keratitis (DLK)
Therapeutic Penetrating Keratoplasty in Fungal Keratitis: Prospective Study Sonika Gupta Consultant Ophthalmology Max Eye Care New Delhi, India Author.
Long term Follow-up of PK cases with herpetic Leukomas, treated with topical Acyclovir and steroids WORLD CORNEA CONGRESS VII 2015 Ramon Naranjo-Tackman,MD.
CORNEAL SURGERY 1. Penetrating keratoplasty 2. Keratoprosthesis 3. Refractive surgery Radial keratotomy Photorefractive keratectomy (PRK) Laser in-situ.
CHAPTER 2 CORNEAL TRANSPLANTATION
Partnerships for Success: Corneal Transplant in the 21st Century Breakout Session A Presenters: Christopher Blanton, MD Medical Director, Ocular Services,
Dr. K.S.SIDDHARTHAN Aravind Eye Hospital Coimbatore
Somasheila I. Murthy, Prashant Garg, Pravin K. Vaddavalli
Table 2.1.1: Number of Cornea Transplantation and Transplant Rate per million population (pmp), Year No.
Table 2.1.1: New Transplant Rate per million population (pmp), Year New transplants
OCULAR HYPERTENSION AFTER PENETRATING KERATOPLASTY F Orucov, E Strassman, D Landau, J Frucht-Pery and A Solomon, Department of Ophthalmology, Hadassah-Hebrew.
Outcome of therapeutic keratoplasty in fungal keratitis Sonika Gupta, MS Assistant Professor, GMCH, Chandigarh, India Author has no financial interest.
"Management of Advanced Keratoconus with Deep Anterior Lamellar Keratoplasty (DALK).” Rohanah A., Thiageswary U. Department of Ophthalmology, Hospital.
Glaucoma and Penetrating Keratoplasty : Incidence, Risk Factors, and Outcomes Sonika Gupta Consultant Ophthalmology Max Eye Care New Delhi, India Author.
Indications for and Outcomes of Therapeutic Penetrating Keratoplasty Sonika Gupta Consultant Ophthalmology Max Eye Care New Delhi, India Author has no.
Clinical outcome of DALK in Keratoconus – A one year follow up
E-Poster Price Vision Group & Cornea Research Foundation of America Descemet - Stripping Endothelial Keratoplasty :Survival Outcomes in Eyes with Pre-
Incidence of Cataract Extraction After Corneal Transplantation in Young and Middle-Aged Patients Revathi Naadimuthu, MD Gerald W. Zaidman, MD Brandon Mirochnik,
Daniel D. Hayes, MD1; Carolyn Y. Shih, MD1; David C
Deep Anterior Lamellar Keratoplasty (DALK) Vs Penetrating Keratoplasty (PK) in patients with Keratoconus (KC). Dr. K.S.SIDDHARTHAN Aravind Eye Hospital.
Table 2.1.1: Number of Corneal Transplantation and Transplant Rate per million population (pmp), Year
World Cornea Congress VI April 7-9, 2010
The S. Fyodorov EYE MICROSURGERY STATE INSTITUTION, Moscow, Russia,
Authors have no financial interest.
Presentation transcript:

Risk Factors for Graft Rejection in Penetrating Keratoplasty Labbafinejad Medical Center Department of Ophthalmology 2002

n Farid Karimian, MD n Mohammad Ali Javadi, MD n Mohammad Reza Jafari-Nasab, MD n Seyed Mojtaba Hosseini, MD n Arash Anisian, MD Department of Ophthalmology, Labbafinejad Medical Center Ophthalmic Research Center Department of Ophthalmology, Labbafinejad Medical Center Ophthalmic Research Center

Introduction n Penetrating keratoplasty (PK) is the most common human organ transplant n During , 2108 PKs were performed in Iran n The most common cause of graft failure is Immunologic Rejection n 30% of PKs have at least one episode of rejection n 50-70% of graft rejection is treated with corticosteroids

Defined Risk Factors for Graft Rejection n Recipient corneal bed vascularization n loose and irritating suture n Regraft n Bilateral graft n Iridocorneal adhesion n Intraocular and corneal inflammation n Recipient young age n Donor graft size n Eccentric graft n Glaucoma, poor controlled IOP n YAG-capsulotomy

Purpose: To evaluate the significance of risk factors in causing graft rejection in our corneal graft patients in Labbafinejad Medical Center To evaluate the significance of risk factors in causing graft rejection in our corneal graft patients in Labbafinejad Medical Center

Materials and Methods Design of Study: Descriptive- cohort Inclusion Criteria: n PK performed during years n Referral: Sequential, non-randomized n No previous H/O Immunosuppressive use use

Surgical Technique n Donor Cornea: cut from whole globe or preserved in media n Trephination: Barron-Hessburg Vacuum n Donor cornea endothelial punch n Suturing technique: 4 cardinal, later interrupted, running or combined

Definitions for Graft Rejection n Clear graft for at least first 10 days Postop n Epithelial Rejection n Subepithelial infiltrates (SEI) n Endothelial Rejection: - Localized: KP´s, - Localized: KP´s, - Diffuse: Endothelial Rejection Line - Diffuse: Endothelial Rejection Line (Khodadoust), diffuse KP´s, corneal (Khodadoust), diffuse KP´s, corneal edema edema

Treatment and Rejection n Epithelial and SEI: Topical Betamethasone 0.1% n Localized ER: Frequent topical Betamethasone + Systemic Prednisolone n Diffuse ER: Topical and Systemic steroids + subtenon methyl- prednisolone

Statistical Analysis Tests: Chi-square T-test Multivariate Regression Analysis

Results n 295 PK in 286 patients evaluated n Male 61.4%, Female 38.6% n Age: 37 ± 20 years (40 days-90 years) n Follow-up: 20 ± 10 months (24-43 mo)

Results… cont Indications for Penetrating Keratoplasty n Keratoconus (31.9%) n Regraft (13.9%) n Corneal ulcer (perforated or non- perforated) (12.6%) n Traumatic scars (7%) n Corneal chemical burn (2%)

Prognosis according to Indications for PK: Percentage of clear graft n Keratoconus (97.8%) n Corneal dystrophies (96.3%) n PBK (66.7%) n ABK (61.5%) n Vascularized scars (60%) n Regraft (47%) n Trauma (28.6%) n Chemical burn (16.7%)

Results cont.…(3) Graft Rejection Data - Total no. of rejections: 94 (31.8%) - Frequency of rejections: Once: 20.8% Twice: 7.8% Twice: 7.8% Three times: 2% Three times: 2% >3 times: 0.9 % >3 times: 0.9 % - Onset of Rejection: Ave: 7.3 ± 6 mo (20 days-39mo) - During first 6 mo.: 62.8% - During first 6 mo.: 62.8% - first 12 mo.: 87.2% - first 12 mo.: 87.2% - first 14 mo.: 92.6% - first 14 mo.: 92.6%

Types of Rejection: - Endothelial: 20.7% - Endothelial: 20.7% - Multi-layer: 6.1% - Multi-layer: 6.1% - SEI: 3.1% - SEI: 3.1% Graft Clarity: -Clear: 70.6% -Clear: 70.6% -Non-clear: 29.4% Rejection cause: 6.1% -Non-clear: 29.4% Rejection cause: 6.1% Time of Rejection: - April: 4.1% > July and Sept.: 3.4% - April: 4.1% > July and Sept.: 3.4% Results.....cont.(4)

Risk factors of rejection factor Rejection P. value clear failure presence rate graft presence rate graft (%) (%) 1- Age < 40y/o > 40y/o > 40y/o Corneal vasularization Mild Mild Moderate Moderate Severe P<0.001 Severe P<0.001 Avascular Avascular Regraft first graft P<0.001 first graft P< Results...cont.(5)

Results......cont.(6) Risk factors of rejection factor Rejection P. value clear failure presence rate graft presence rate graft (%) (%) 4- Bilateral graft unilateral unilateral P<0.001 P< Donor size > 8mm < 8mm < 8mm Iridocorneal < Adhesion Adhesion 7- Irritating suture Active intraocular inflammation < inflammation < Secondary anterior segment surgery segment surgery

Results....cont.(7) Risk factors of rejection factor Rejection P value clear failure presence rate graft presence rate graft (%) (%) 10- Eccentric graft Trauma scar < Poor controlled IOP (N.S) 13- Previous rejection Graft ulcer HSK recurrence

Discussion and Conclusions n The most common causes of PK at LMC are different from Western reports (Kerataconus vs ABK-PBK) n The most common type of Rejection is Endothelial n Age (>40 vs 40 vs <40 years) was not a risk factor for rejection n Severity of vascularization increases rate of rejection and graft failure

Discussion and Conclusions…. Cont.(1) n Regraft increases risk of rejection n Bilateral graft (vs unilateral) was not a risk factor (controversial in previous reports) probably due to main primary indications for PK n There was no significant difference in graft size (>8 vs 8 vs <8 mm) as risk factor

Discussion and Conclusions… cont. (2) n Iridocorneal adhesions, irritating sutures, active intraocular inflammation, secondary intraocular surgeries, eccentricity of graft, poor controlled IOP, presence of graft ulcer and recurrence of Herpes:Increase risk of rejection and consequently graft failure